|
|
||||||||
Lipids, Lipoproteins, and Cardiovascular Risk Factors |
ová2
1 Department of Pathology and Laboratory Medicine, University of British Columbia, Healthy Heart Program/Lipid Clinic, St. Pauls Hospital, Vancouver, BC V6Z 1Y6, Canada.
2 Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic 14220.
aAddress correspondence to this author at: Healthy Heart Program, St. Pauls Hospital, B180-1081 Burrard St., Vancouver, BC V6Z 1Y6, Canada. Fax 604-806-8590/3; e-mail jifr{at}interchange.ubc.ca.
Background: We examined the predictive value of various clinical and biochemical markers for angiographically defined coronary artery disease (aCAD). Specifically, we assessed the value of the ratio of plasma triglyceride (TGs) to HDL-cholesterol (HDL-C) and the fractional esterification rate of cholesterol in plasma depleted of apolipoprotein B (apoB)-containing lipoproteins (FERHDL), a functional marker of HDL and LDL particle size.
Methods: Patients (788 men and 320 women) undergoing coronary angiography were classified into groups with positive [aCAD(+)] and negative [aCAD(-)] findings. Patient age, body mass index, waist circumference, blood pressure (BP), medications, drinking, smoking, exercise habits, and plasma total cholesterol (TC), LDL-cholesterol (LDL-C), HDL-unesterified cholesterol, HDL-C, TGs, FERHDL, apoB, log(TG/HDL-C), and TC/HDL-C were assessed. Lipids and apoproteins were measured by standard laboratory procedures; FERHDL was determined by a radioassay.
Results: Members of the aCAD(+) group were older and had a higher incidence of smoking and diabetes than those in the aCAD(-) group. The aCAD(+) group also had higher TG, apoB, FERHDL, and log(TG/HDL-C) and lower HDL-C values. aCAD(+) women had greater waist circumference and higher plasma TC and TC/HDL-C. aCAD(+) men, but not women, had higher plasma LDL-C. In the multivariate logistic model, the significant predictors of the presence of aCAD(+) were FERHDL, age, smoking, and diabetes. If only laboratory tests were included in the multivariate logistic model, FERHDL appeared as the sole predictor of aCAD(+). Log(TG/HDL-C) was an independent predictor when FERHDL was omitted from multivariate analysis.
Conclusions: FERHDL was the best laboratory predictor of the presence of coronary atherosclerotic lesions.
The following articles in journals at HighWire Press have cited this article:
![]() |
R. Movva and D. J. Rader Laboratory Assessment of HDL Heterogeneity and Function Clin. Chem., May 1, 2008; 54(5): 788 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W.J. Lee, J. S. Hill, K. R. Walley, and J. J. Frohlich Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. Can. Med. Assoc. J., February 14, 2006; 174(4): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease Clin. Chem., January 1, 2005; 51(1): 132 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brehm, G. Pfeiler, G. Pacini, H. Vierhapper, and M. Roden Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity Clin. Chem., December 1, 2004; 50(12): 2316 - 2322. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, P. Fan, E. Shimoji, H. Xu, K. Takeuchi, C. Bian, and K. Saku Inhibition of Cholesteryl Ester Transfer Protein Activity by JTT-705 Increases Apolipoprotein E-Containing High-Density Lipoprotein and Favorably Affects the Function and Enzyme Composition of High-Density Lipoprotein in Rabbits Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1910 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dobiasova Atherogenic Index of Plasma [Log(Triglycerides/HDL-Cholesterol)]: Theoretical and Practical Implications Clin. Chem., July 1, 2004; 50(7): 1113 - 1115. [Full Text] [PDF] |
||||
![]() |
M. H. Tan, D. Johns, and N. B. Glazer Pioglitazone Reduces Atherogenic Index of Plasma in Patients with Type 2 Diabetes Clin. Chem., July 1, 2004; 50(7): 1184 - 1188. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |